Texas Wound & Lymphedema Center - TX Harris, Tomball 77375

Texas Wound & Lymphedema Center entered the industry of Clinics in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6214930, which describes it as a Clinics. For further clarification, the SIC classifies this business under the code 8011 and described it as a Clinics. The business provides service to the B2C market.

To acquire more information, please contact Lynn Lebouef, Chief Executive Officer by calling (281) 401-7943 during business hours. You can also write to the business’ Single Location at 605 Holderrieth Boulevard, Tomball, Texas TX 77375. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Texas Wound & Lymphedema Center
Representative: Lynn Lebouef, Chief Executive Officer
Place of Business: 605 Holderrieth Boulevard, Tomball, TX 77375
Contact Number: (281) 401-7943
Type of Service: Clinics
SIC Number: 8011
NAICS Number: 6214930
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2007
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Texas Wound & Lymphedema Center is a company operating from Harris, Texas providing professional Clinics and relevant B2C variables. It was founded in 2007 and registered with the SIC code 8011 as Clinics, and with the NAICS code 6214930 as Clinics.

With a current employee count of 1 to 4, Texas Wound & Lymphedema Center has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Lynn Lebouef, Chief Executive Officer at (281) 401-7943 for related queries, or to locate its Single Location using the coordinates 30.08882,-95.62392.

The Single Location can also be found at the street address 605 Holderrieth Boulevard in Tomball, Texas 77375 and can be engaged online through the company website at , the company Twitter , and Facebook page .